|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.37 USD | +3.49% |
|
+6.88% | -42.14% |
| Mar. 12 | Transcript : Relay Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM | |
| Feb. 23 | Relay Therapeutics Q4 Loss Widens, Reports No Revenue | MT |
Relay Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 25.55 million compared to USD 1.38 million a year ago. Net loss was USD 341.97 million compared to USD 290.51 million a year ago.
Basic loss per share from continuing operations was USD 2.79 compared to USD 2.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.14% | 843M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
RELAY THERAPEUTICS, INC. 
